In a study dedicated to correlating the loss-of-function mutations in TP53 with breast cancer prognosis, the authors found that mutations are more frequent in high-grade, large-size, node-positive cases and also in oestrogen- and progesterone-receptor-negative tumours [22]. Here, TP53 is linked to breast cancer.